Brief: Hoth Therapeutics Secures Japanese Patent For Breakthrough HT-KIT Platform Targeting Mast Cell Diseases
12/06/2025 14:17
June 12 (Reuters) - Hoth Therapeutics Inc HOTH.O: HOTH THERAPEUTICS SECURES JAPANESE PATENT FOR BREAKTHROUGH HT-KIT PLATFORM TARGETING MAST CELL DISEASES Source text: ID:nPn8y11H3a Further company coverage: HOTH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rocket One
See all newsBrief: Rocket One Signs AI Chip Development Agreement Targeting Ultra-Low-Power Magnetic Computing
Brief: Rocket One Signs Agreement To Advance Nanomagnetic Ai Chip Technology And Device Prototyping
Brief: Rocket One Signs Patent License Agreement With U.S. Air Force For Technology Designed To Capture And Neutralize Hostile Drones
Brief: Rocket One To Buy 100% Ownership Of Tracer Drone Technologies
Brief: Rocket One And Nasa Reach Agreement To Advance Space Ai Technology